Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

about

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

Item

http://www.wikidata.org/entity/Q47346236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@en

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@nl

type

Item

label

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@en

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@nl

prefLabel

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@en

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@nl

P1476

Non-persistence in ischaemic stroke: Risk of recurrent vascular events.

@en

P2093

G de Jong

http://www.w3.org/2001/XMLSchema#string

M Rijkmans

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010

Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patient

Adherence to Medication

Relationship between non-specific prescription pill adherence and ischemic stroke outcomes

Secondary preventive medication persistence and adherence 1 year after stroke

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services.

Tolerability of Antihypertensive Medications in Older Adults.

Depression but not anxiety predicts recurrent cerebrovascular events.

Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.

Persistence with antihypertensive agents for 12 months after ischemic stroke reduces the rates of death and dependency.

P304

288-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12813

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Peter van den Berg

P577

2017-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29218700

http://www.w3.org/2001/XMLSchema#string